S
Stockadora
Back to Insider Trading View Full Company Profile

ARQT

UNKNOWN

Arcutis Biotherapeutics, Inc.

CIK: 0001787306

Strong Sell (90% confidence)

Last activity: Mar 2, 2026

Financial Metrics

As of Dec 31, 2025 (10-K)

Insider Roster (7 total, 7 active)

Insider Buys Sells Net Value Holdings
Watanabe Todd
See Remarks
 		0 3 -$1.45M
787,025 shares
$19.80M
Matsuda Masaru
See Remarks
 		0 8 -$1.34M
137,125 shares
$3.45M
Leonard Keith R
DIRECTOR
 		0 1 -$997K
22,123 shares
$562K
Burnett Patrick
See Remarks
 		0 8 -$959K
121,295 shares
$3.05M
Welgus Howard G.
DIRECTOR
 		0 3 -$797K
49,744 shares
$1.28M
Edwards Larry Todd
See Remarks
 		0 3 -$145K
175,281 shares
$4.41M
Vairavan Latha
SVP Chief Financial Officer
 		0 3 -$106K
87,835 shares
$2.21M

Recent Transactions

SELL Leonard Keith R (DIRECTOR)

39,272 shares @ $25.39

$997K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Watanabe Todd (See Remarks)

36,281 shares @ $25.16

$913K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Welgus Howard G. (DIRECTOR)

10,000 shares @ $25.65

$257K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

6,553 shares @ $25.16

$165K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

6,106 shares @ $25.16

$154K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Edwards Larry Todd (See Remarks)

3,584 shares @ $25.16

$90K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Vairavan Latha (SVP Chief Financial Officer)

2,772 shares @ $25.16

$70K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

1,987 shares @ $25.70

$51K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Watanabe Todd (See Remarks)

1,068 shares @ $25.91

$28K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

193 shares @ $25.91

$5K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

181 shares @ $25.91

$5K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Edwards Larry Todd (See Remarks)

103 shares @ $25.91

$3K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Vairavan Latha (SVP Chief Financial Officer)

81 shares @ $25.91

$2K

Mar 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

3,325 shares @ $27.95

$93K

Feb 27, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

9,794 shares @ $25.81

$253K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Watanabe Todd (See Remarks)

19,833 shares @ $25.50

$506K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

19,379 shares @ $25.24

$489K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Welgus Howard G. (DIRECTOR)

10,000 shares @ $25.05

$250K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

8,562 shares @ $24.97

$214K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

7,983 shares @ $25.50

$204K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Matsuda Masaru (See Remarks)

4,714 shares @ $25.63

$121K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

3,675 shares @ $25.50

$94K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Edwards Larry Todd (See Remarks)

2,052 shares @ $25.50

$52K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Vairavan Latha (SVP Chief Financial Officer)

1,320 shares @ $25.50

$34K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

2,490 shares @ $28.98

$72K

Jan 5, 2026

Conviction: | View SEC Filing →
SELL Welgus Howard G. (DIRECTOR)

10,000 shares @ $28.96

$290K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

1,156 shares @ $29.39

$34K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

541 shares @ $28.81

$16K

Dec 31, 2025

Conviction: | View SEC Filing →
SELL Burnett Patrick (See Remarks)

11,500 shares @ $28.94

$333K

Dec 15, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.